NEK1
protein-codingNIMA related kinase 1
Gene summary
The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~242.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0054750
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009894
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0054750
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0054750
Submitter: ClinGen
*NEK1* was first reported in relation to autosomal dominant amyotrophic lateral sclerosis (ALS) type 24 in 2015 (Cirulli et al., PMID: 25700176). *NEK1* encodes never in mitosis gene a-related kinase 1 (Nek1) and has a role in cell cycle control and cilia regulation. *NEK1* has also been associated with autosomal recessive short-rib thoracic dysplasia 6 with or without polydactyly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found a difference in molecular mechanism, inheritance pattern, and phenotypic variability between this disease and ALS type 24. Therefore, the following disease entities have been split into two disease entities: ALS type 24 (OMIM: 617892) and short-rib thoracic dysplasia 6 with or without polydactyly (OMIM:263520). The association between *NEK1* and ALS was first established in an exome-wide gene burden analysis that identified an association between loss of function rare variants in the gene and the phenotype based on the exome sequencing of 2874 ALS cases and 6405 controls (Cirulli et al., PMID: 25700176). This curation also includes an additional 13 case-control analyses from 11 publications (PMIDs: 25700176, 26945885, 27455347, 28935222, 29149916, 30940688, 30976013, 31768050, 32920598, 34544842, 31475037). Additionally, 40 variants, including missense, nonsense, frameshift, and splicing variants, reported in 40 probands in 10 publications (PMIDs: 26945885, 28935222, 30093141, 31108397, 31475037, 32462798, 32772750, 32920598, 33445179, 34564799) are included in this curation. Based on this curation, the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function, although missense variants have also been reported in ALS probands. This gene-disease association is also supported by experimental evidence describing physical interaction with other known ALS associated genes and functional alterations in mutated patient cells (PMIDs: 30992335, 29929116, 25700176), although experimental evidence remains marginal overall. In summary, *NEK1* is definitively associated with autosomal dominant ALS type 24. This has been repeatedly demonstrated in both the research and clinical diagnostic settings as shown by the genetic evidence and has been upheld over time. Although, we believe that more experimental evidence is needed to gain a greater understanding of the involvement of *NEK1* in ALS pathophysiology. It is important to understand that in the clinical diagnostic setting the identification of missense variants of uncertain significance may be common and variant interpretation must be completed with caution. This classification was approved by the ClinGen ALS GCEP on 02/24/2021 (SOPv8).
Inheritance Pattern: AR
Disease ID:MONDO:0019662
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009642
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0054750
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009894
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009894
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal
Intervention: Audiologic/Otolaryngologic; Cardiovascular
Rationale: Orofaciodigital syndrome II can include hearing loss, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Short-rib thoracic dysplasia 6 with or without polydactyly can involve congenital cardiac anomalies, and awareness may allow early management
Comments: Heterozygous (digenic) variants in both NEK1 and DYNC2H1 can result in disease
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NEK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001199397.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 147 | 2 | 159 | ||
| missense | 3 | 8 | 405 | 43 | 3 | 462 |
| nonsense | 17 | 19 | 4 | 40 | ||
| start loss | 1 | 1 | ||||
| frameshift | 26 | 25 | 5 | 56 | ||
| splice donor/acceptor (+/-2bp) | 2 | 24 | 4 | 30 | ||
| Total | 48 | 77 | 428 | 190 | 5 | 748 |
Highest pathogenic variant AF is 0.00020822926
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001186326.1 | 34 | MANE Select | |
| Ensembl | ENSP00000424757.2 | 34 | MANE Select | |
| RefSeq | NP_001186327.1 | 33 | Standard | |
| RefSeq | NP_001186328.1 | 31 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| nek1 | Danio rerio | Structure: photoreceptor cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein phosphorylation
- cellular response to DNA damage stimulus
- cell cycle
- peptidyl-tyrosine phosphorylation
- signal transduction by protein phosphorylation
Molecular Function
- protein kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
- protein binding
- ATP binding
Cellular Component
- pericentriolar material
- nucleus
- cytoplasm
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000507142
- Coding exons
- 34
- Length
- 219355
- Individuals with no LoFs
- 124563
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 91
- Defined
- 124654
- p
- 0.000365
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 542 | 617 | 0.879 | 0.0000302 | 8416 |
| Missense (PolyPhen) | 154 | 207.39 | 0.74257 | 2943 | ||
| Synonymous | -0.138 | 213 | 210 | 1.01 | 0.0000106 | 2303 |
| Loss of Function | 2.54 | 51 | 74.7 | 0.683 | 0.00000381 | 1004 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00033 | 0.00032 | rare |
| Latino/Admixed American | 0.00044 | 0.00038 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00035 | 0.00033 | rare |
| Finnish | 0.000099 | 0.000093 | rare |
| European (Non-Finnish) | 0.00045 | 0.00043 | rare |
| South Asian | 0.00043 | 0.00042 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617). {ECO:0000250|UniProtKB:P51954, ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:21211617}.;
- Disease
- DISEASE: Amyotrophic lateral sclerosis 24 (ALS24) [MIM:617892]: A form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:26945885, ECO:0000269|PubMed:27455347}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- LoFtool
- 0.968
- RVIS EVS
- -0.08
- RVIS percentile EVS
- 47.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.329
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |